Yongin, South Korea

Mi Jeong Kim

This inventor holds 1 USPTO granted patent. Top assignee: Avixgen Inc.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mi Jeong Kim. Retrieved from https://idiyas.com/inventor/mi-jeong-kim-tkixsdmj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mi Jeong Kim: Innovator in Dry Eye Disease Treatment

Introduction

Mi Jeong Kim is a prominent inventor based in Yongin, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of dry eye diseases. Her innovative approach has led to the development of a unique composition that addresses this common ailment.

Latest Patents

Mi Jeong Kim holds a patent for a pharmaceutical composition aimed at preventing and treating dry eye diseases. This composition contains imatinib as the active ingredient. The invention specifically relates to an eye bath lotion designed to alleviate symptoms associated with dry eye syndrome. Imatinib effectively protects the corneal epithelia and inhibits degeneration, making it a valuable option for treating dry eye conditions.

Career Highlights

Throughout her career, Mi Jeong Kim has focused on advancing medical treatments that improve patient quality of life. Her work at Avixgen Inc. has been instrumental in bringing her innovative ideas to fruition. With her expertise, she has contributed to the development of effective solutions for eye health.

Collaborations

(Section skipped due to space constraints.)

Conclusion

Mi Jeong Kim's contributions to the field of pharmaceuticals, particularly in the treatment of dry eye diseases, highlight her role as an innovative inventor. Her work continues to pave the way for advancements in eye care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…